OakChart

Lipocine Inc

LPCNHealthcare·Biotechnology·USA·Nano·NASD·Nov 11 • 3:59 PM ET

1.590.00 (0.00%)
2026-11-12 00:42 CET
Market cap
17.61 USD m
Revenue, TTM
3.74 USD m
Net income, TTM
-9.33 USD m
Free cash flow, TTM
-10.01 USD m
EPS diluted, TTM
-1.36
P/E
-
Compare

Price

LPCN against its 20, 50 and 200-day averages
2050200beat
2.003.004.005.0052.9M105.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LPCNclose 1.5920-day 1.5350-day 1.88200-day 3.551.5952w low

87.1% under the 52-week high of 12.37 on 15 Jan 2026. 52-week low 1.36 on 2 Nov 2026. Last 15 sessions, 27.9% high to low

Volume 0.12× normal · the line is the 50-bar volume average

Profile

LPCN
52-week range, 2% of the way up
1.3612.37

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Employees14
IPOJun 15, 2012
Beta0.48
ATR, 14d0.13
Rel volume0.12
Short float3.09%
Insider own4.98%
Inst own26.96%

Snapshot

6 groups

Valuation

Index-
Market Cap17.61M
Enterprise Value-3.85M
Income-9.33M
Sales3.74M
Book/sh2.57
Cash/sh1.94
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees14
IPOJun 15, 2012

Ratios

P/E-
Forward P/E-
PEG-
P/S4.71
P/B0.62
P/C0.82
P/FCF-
EV/EBITDA-
EV/Sales-1.03
Quick Ratio11.36
Current Ratio11.36
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.36
EPS next Y-1.22
EPS next Q-0.32
EPS this Y18.93%
EPS next Y11.31%
EPS next 5Y17.47%
EPS past 3/5Y5.11% 22.70%
Sales past 3/5Y58.12% -
EPS Y/Y TTM-33.44%
Sales Y/Y TTM-13.37%
EPS Q/Q86.27%
Sales Q/Q1898.77%
EarningsNov 05 BMO
EPS/Sales Surpr.77.46% 1335.80%

Ownership

Insider Own4.98%
Insider Trans7.31%
Inst Own26.96%
Inst Trans-5.29%
ROA-47.52%
ROE-52.86%
ROIC-44.09%
Gross Margin98.42%
Oper. Margin-269.06%
Profit Margin-249.16%
SMA203.85%
SMA50-15.64%
SMA200-55.26%
Trades-

Technical

Shs Outstand11.07M
Shs Float10.52M
Short Float3.09%
Short Ratio0.18
Short Interest0.33M
52W High12.37 -87.15%
52W Low1.36 16.91%
Volatility9.41% 7.61%
ATR (14)0.13
RSI (14)46.26
Beta0.48
Rel Volume0.12
Avg Volume1.80M
Volume206,946

Performance

Perf Week10.42%
Perf Month-1.85%
Perf Quarter-22.82%
Perf Half Y-31.47%
Perf YTD-80.20%
Perf Year-44.98%
Perf 3Y-36.40%
Perf 5Y-92.07%
Perf 10Y-97.37%
Recom2.00
Target Price5.00
Prev Close1.59
Price1.59
Change %0.00%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Apr 06, 2026DowngradeHH.C. WainwrightBuy → Neutral
Jun 24, 2021InitiatedCCantor FitzgeraldOverweight$3+88.7%
Dec 10, 2020UpgradeLLadenburg ThalmannNeutral → Buy$3+88.7%
Jan 12, 2018ReiteratedHH.C. WainwrightBuy$10 → $3+88.7%
Jan 11, 2018DowngradeCCanaccord GenuityBuy → Hold$11 → $2+25.8%
Dec 08, 2017ResumedHH.C. WainwrightBuy$10+528.9%
Oct 07, 2016InitiatedHH.C. WainwrightBuy$25+1,472.3%
Jul 22, 2015InitiatedRROTH CapitalBuy$36+2,164.2%
Jun 23, 2015InitiatedCCanaccord GenuityBuy$15+843.4%

Peers

Mkt cap
TickerCompanyMkt cap
PTNPalatin Technologies Inc12.22M
DAREDare Bioscience Inc13.65M
ORMPOramed Pharmaceuticals Inc171.80M
RANIRani Therapeutics Holdings Inc79.18M
ENTXEntera Bio Ltd560.73M
VERUVeru Inc36.49M
SKYESkye Bioscience Inc4.06M
AEONAEON Biopharma Inc10.12M
MTNBMatinas Biopharma Holdings Inc0.91M
CINGCingulate Inc67.47M

Insider trading

7 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Higuchi John W.DirectorSep 30 '26Buy2.2315,97035,613241,365Oct 01 08:28 PM
Higuchi John W.DirectorSep 29 '26Buy2.159,03719,430225,395Oct 01 08:28 PM
Higuchi John W.DirectorSep 28 '26Buy2.1612,56127,132216,358Sep 30 08:38 PM
Higuchi John W.DirectorApr 07 '26Buy2.0340,00081,200203,797Apr 07 06:27 PM
Higuchi John W.DirectorApr 06 '26Buy2.05123,000252,150163,797Apr 06 07:01 PM
Patel Mahesh V.Chief Executive OfficerApr 06 '26Buy2.0325,00050,750160,679Apr 06 06:33 PM
Patel Mahesh V.Chief Executive OfficerApr 02 '26Buy2.0225,00050,500135,679Apr 02 05:05 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 665.71M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-05-0.080-0.355-0.0802.290.162
2026Q22026-08-04-0.320-0.400-0.3190.190.211
2026Q12026-05-07-0.540-0.485-0.5401.190.162
2025Q42026-03-10-0.420-0.610-0.4161.120.122
2025Q32025-11-06-0.590-0.540-0.5890.110.242
2025Q22025-08-05-0.410-0.400-0.4120.620.232
2025Q12025-05-08-0.350-0.350-0.3490.090.351
2024Q42025-03-130.330-0.4000.3333.492.611
2024Q32024-11-07-0.440-0.485-0.4150.000.132
2024Q22024-08-08-0.560-0.780-0.5740.090.291
2024Q12024-05-090.660-0.6820.6617.620.001
2023Q42024-03-08-0.510-0.470-0.4320.200.001
2023Q32023-11-08-1.270-0.600-1.271-3.120.312
2023Q22023-08-10-0.680-0.640-0.6830.000.263
2023Q12023-05-11-0.680-0.425-0.7620.060.782
2022Q42023-03-10-0.340-0.510-0.4280.001.313

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-8.500-8.500-8.5440.170.20
2020FY-6.460-6.290-6.4000.000.00
2021FY-0.170-2.493-0.12416.143.75
2022FY-2.210-2.153-2.0680.501.81
2023FY-3.140-2.990-3.143-2.85-3.07
2024FY0.002-0.730-0.00211.2010.32
2025FY-1.690-1.965-1.6901.980.95
2026FY--1.370--1.63
2027FY--1.215--0.75
2028FY--0.950--1.20
2029FY--0.750--2.89
2030FY--0.350--9.39

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-052010.130.100.15
2026Q4S2026-09-182000.160.100.23
2026Q4S2026-08-041000.230.230.23
2026Q4S2026-07-121000.230.230.23
2026Q4S2026-05-082000.160.100.23
2026Q4S2026-03-162000.160.100.23
2026Q4S2026-03-101000.100.100.10
2026Q4S2025-11-111000.100.100.10
2026Q4S2025-11-101000.100.100.10
2026Q4S2025-11-091000.100.100.10
2026Q4S2025-11-081000.100.100.10
2026Q4S2025-11-071000.100.100.10
2026Q4S2025-11-061000.100.100.10
2026Q4S2025-11-051000.100.100.10

Estimate history

EPS, annual-17.85-9.283-8.544-6.4-0.124-2.068-3.143-0.002-1.767-1.3561
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.4150.333-0.349-0.412-0.589-0.416-0.54-0.319-0.081
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00.4280.165016.1410.50.1111.1981.9773.74
Period201720182019202020212022202320242025TTM
Sales, quarterly03.4910.0940.6230.1151.1450.1190.192.29
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1.2511.2782.2154.125.1945.2075.3165.3486.1588.245
Period201720182019202020212022202320242025MRQ
Shares, quarterly5.3485.3485.355.3745.426.1587.4758.2448.245
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3.741.9811.200.110.5016.140.000.160.43
Cost of Goods Sold Incl. D&A0.060.060.040.030.010.000.00--
Gross Profit3.691.9211.160.080.4916.14-0.00--
Selling, General and Administrative Excl. Other13.7612.2912.3115.0512.6112.9917.9913.0511.74
Research and Development9.498.527.3110.158.557.679.747.456.46
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-10.08-10.37-1.16-14.97-12.123.15-18.00-12.90-11.33
Interest Expense0.000.000.00-0.030.200.390.340.79
Unusual Expense0.000.00-0.022.75-0.823.642.66-0.240.00
Net Income Before Taxes-9.33-9.630.01-16.35-10.76-0.63-20.96-13.01-11.66
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-9.33-9.630.01-16.35-10.76-0.63-20.96-13.01-11.66
Net Income From Continuing Operations-9.33-9.630.01-16.35-10.76-0.63-20.96-13.01-11.66
Net Income-9.33-9.630.01-16.35-10.76-0.63-20.96-13.01-11.66
EPS (Recurring)-1.13-1.77-0.00-2.78-2.180.37-5.83-8.65-9.28
EPS (Basic, Before Extraordinaries)-1.36-1.770.00-3.10-2.07-0.12-6.40-8.54-9.28
EPS (Diluted)-1.36-1.77-0.00-3.14-2.07-0.12-6.40-8.54-9.28
EBITDA-10.02-10.31-1.11-14.94-12.113.15-17.99-12.88-11.31
Non-Operating Income (Expense)0.750.741.151.370.570.070.080.000.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.230.190.320.520.500.441.000.761.15
Price To Earnings Ratio----8.55----
Price To Sales Ratio4.8422.142.36133.6770.385.34-60.3864.85
Gross Margin98.4296.9399.6373.9498.11100.00---
Operating Margin-269.06-524.69-10.31-13,610.84-2,423.8819.49--7,818.83-2,646.03
Net Margin-249.16-487.060.07-14,867.37-2,151.73-3.93--7,883.72-2,724.11
Shares Outstanding8.256.165.355.325.215.194.122.211.28
Market Capitalization17.6117.6126.1014.8335.2187.5095.2514.4928.25

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue2.290.190.121.150.110.620.093.49
Cost of Goods Sold Incl. D&A0.010.010.010.010.010.020.020.02
Gross Profit2.280.180.101.130.100.610.083.48
Selling, General and Administrative Excl. Other3.143.023.953.653.463.012.171.93
Research and Development2.062.032.752.662.692.121.051.06
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.87-2.84-3.85-2.52-3.36-2.40-2.091.55
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00-0.00
Net Income Before Taxes-0.67-2.62-3.67-2.37-3.19-2.21-1.861.78
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-0.67-2.62-3.67-2.37-3.19-2.21-1.861.78
Net Income From Continuing Operations-0.67-2.62-3.67-2.37-3.19-2.21-1.861.78
Net Income-0.67-2.62-3.67-2.37-3.19-2.21-1.861.78
EPS (Recurring)-0.08-0.32-0.54-0.42-0.59-0.41-0.350.33
EPS (Basic, Before Extraordinaries)-0.08-0.32-0.54-0.42-0.59-0.41-0.350.33
EPS (Diluted)-0.08-0.32-0.54-0.42-0.59-0.41-0.350.33
EBITDA-0.85-2.83-3.83-2.50-3.35-2.39-2.071.56
Non-Operating Income (Expense)0.200.220.180.150.170.200.230.23
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.070.050.070.040.040.070.060.08
Price To Earnings Ratio------623.53-
Price To Sales Ratio4.8413.4027.1223.163.574.024.632.33
Gross Margin99.3692.2987.5998.6987.6797.4183.4199.55
Operating Margin-37.93-1,495.14-3,224.09-219.65-2,933.51-386.03-2,226.8244.27
Net Margin-29.09-1,379.59-3,075.37-206.92-2,781.46-354.13-1,986.7851.04
Shares Outstanding8.258.247.486.165.425.375.355.35
Market Capitalization17.6121.1158.3244.5815.4416.9117.0126.10

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments14.9321.6322.0432.5344.6224.6719.0720.2521.47
Short Term Receivables0.010.120.050.660.250.000.020.043.34
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets1.930.570.770.951.510.660.550.520.41
Total Current Assets16.8822.3222.8634.1446.3825.3319.6320.8125.22
Net Property, Plant & Equipment0.100.170.120.130.010.000.000.020.08
Total Investments and Advances0.000.000.000.002.020.000.000.000.00
Long-Term Note Receivable--0.003.254.05----
Intangible Assets--------0.00
Other Assets0.020.020.020.020.020.020.020.020.03
Total Assets17.0122.5123.0037.5452.4825.3519.6620.8525.33
Short Term Debt Incl. Current Port. of LT Debt0.000.000.020.002.313.333.333.330.00
Accounts Payable0.970.271.400.601.291.601.180.670.60
Other Current Liabilities1.561.241.221.082.021.650.450.495.75
Total Current Liabilities2.531.512.631.685.626.584.964.496.35
Long Term Debt0.000.000.000.000.002.263.816.930.00
Provision for Risks Charges0.000.000.000.000.500.000.000.000.00
Other Liabilities0.000.000.000.230.801.174.590.000.00
Total Liabilities2.531.512.631.916.9110.0113.3711.426.35
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity14.4821.0020.3735.6345.5715.346.299.4318.98
Total Shareholders Equity14.4821.0020.3735.6345.5715.346.299.4318.98
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity14.4821.0020.3735.6345.5715.346.299.4318.98
Total Liabilities & Stockholders Equity17.0122.5123.0037.5452.4825.3519.6620.8525.33
Book Value Per Share2.353.933.836.848.773.722.847.3815.17
Tangible Book Value Per Share2.353.933.836.848.773.722.847.3815.17
Full-Time Employees141617171311121014
Price to Book Ratio0.621.370.660.941.926.212.302.993.07
Return on Assets-48.730.04-54.02-23.90-1.63-93.15-64.22-50.50-79.68
Return on Equity-54.280.04-58.40-26.50-2.08-193.85-165.47-82.07-93.26
Return on Invested Capital-66.500.04-80.28-30.19-1.39-119.13-128.76-71.27-110.55
Quick Ratio6.6814.758.6920.348.263.853.954.633.97
Current Ratio6.6814.758.6920.348.263.853.954.633.97

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-9.33-9.630.01-16.35-10.76-0.63-20.96-13.01-11.66
Depreciation0.060.060.040.030.010.000.000.020.02
Other Funds (Non Cash)0.010.05-0.312.45-0.300.824.140.861.56
Funds from Operations-9.26-9.52-0.26-13.87-11.050.18-16.82-12.14-10.08
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.75-0.24-0.962.01-0.92-4.591.520.47-1.99
Cash from Operating Activities-10.01-9.76-1.22-11.87-11.97-4.41-15.30-11.67-12.08
Capital Expenditures0.000.00-0.09-0.01-0.13-0.010.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.00--
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-7.435.892.5413.1014.43-43.773.893.0011.29
Purchase of Investments-32.03-14.71-32.86-22.90-45.07-48.42-6.32-16.85-25.55
Sale Or Maturity of Investments24.6020.6035.4036.0059.504.6510.2119.8536.84
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.01
Cash from Investing Activities-7.435.892.4513.0814.29-43.783.893.0011.29
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock16.132.870.210.400.1930.2622.3313.650.65
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock16.132.870.210.400.1930.2622.3313.650.65
Proceedsfrom Stock Options16.122.870.210.40-0.0230.2514.6613.600.65
Issuance or Reduction of Debt, Net0.000.000.000.00-1.67-3.33-1.43-3.3310.00
Change in Long Term Debt0.000.000.000.00-1.67-3.33-1.43-3.3310.00
Issuance of Long Term Debt0.000.000.000.000.000.000.230.0010.00
Reduction of Long Term Debt0.000.000.000.00-1.67-3.33-1.67-3.330.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.650.000.000.000.00
Other Financing Activities Uses0.000.000.000.00-0.650.000.000.000.00
Cash from Financing Activities16.132.870.210.40-2.1326.9220.9010.3210.65
Net Change in Cash-1.31-1.001.431.620.20-21.279.491.659.87
Free Cash Flow-10.01-9.76-1.31-11.88-12.10-4.42-15.30-11.67-12.08
Preferred Dividends (Cash Flow)-0.000.00-0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments21.4623.2724.7314.9315.1317.94
Short Term Receivables0.210.100.110.010.120.12
Inventories0.000.000.000.000.000.00
Other Current Assets1.450.370.401.930.680.36
Total Current Assets23.1123.7425.2416.8815.9318.42
Net Property, Plant & Equipment0.060.070.090.100.120.13
Total Investments and Advances0.000.000.000.000.000.00
Other Assets0.020.020.020.020.020.02
Total Assets23.2023.8425.3617.0116.0718.58
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable0.540.681.560.970.860.44
Other Current Liabilities1.491.390.971.561.071.01
Total Current Liabilities2.032.072.532.531.931.45
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities2.032.072.532.531.931.45
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity21.1621.7722.8314.4814.1417.13
Total Shareholders Equity21.1621.7722.8314.4814.1417.13
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity21.1621.7722.8314.4814.1417.13
Total Liabilities & Stockholders Equity23.2023.8425.3617.0116.0718.58
Book Value Per Share2.572.643.052.352.613.19
Tangible Book Value Per Share2.572.643.052.352.613.19
Full-Time Employees---14--
Price to Book Ratio0.620.843.403.080.890.88
Return on Assets-47.52-55.89-49.87-48.73-29.78-21.66
Return on Equity-52.86-60.94-54.41-54.28-32.92-23.51
Return on Invested Capital-3.15-12.05-16.08-16.37-22.53-12.88
Quick Ratio11.3611.489.996.688.2512.71
Current Ratio11.3611.489.996.688.2512.71

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.67-2.62-3.67-2.37-3.19-2.21
Depreciation0.010.010.010.010.010.02
Other Funds (Non Cash)0.06-0.01-0.03-0.010.020.03
Funds from Operations-0.59-2.61-3.69-2.37-3.15-2.16
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.22-0.411.43-0.550.170.27
Cash from Operating Activities-1.81-3.03-2.26-2.92-2.99-1.89
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.581.48-9.901.570.704.50
Purchase of Investments-7.38-5.02-15.20-4.43-5.200.00
Sale Or Maturity of Investments6.806.505.306.005.904.50
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.581.48-9.901.570.704.50
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.001.5111.972.650.140.08
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.001.5111.972.650.140.08
Proceedsfrom Stock Options0.001.5111.962.650.140.08
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.001.5111.972.650.140.08
Net Change in Cash-2.39-0.04-0.191.30-2.142.69
Free Cash Flow-1.81-3.03-2.26-2.92-2.99-1.89

Revenue breakdown

License2024: 10.90M 2025: 1.50M
Royalty2024: 298.14K 2025: 476.68K
United States2024: 11.20M 2025: 1.98M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.3M-1.78M
2026-10-154.49%0.4M7.8M1.74M
2026-09-301.24%0.1M7.9M37.04K
2026-09-151.26%0.1M7.9M43.94K
2026-08-311.28%0.1M7.9M61.72K
2026-08-141.20%0.1M7.9M69.69K
2026-07-311.41%0.1M7.9M78.96K
2026-07-151.56%0.1M7.9M122.65K
2026-06-301.80%0.1M7.9M395.63K
2026-06-151.94%0.2M7.9M390.29K
2026-05-291.15%0.1M7.9M394.25K
2026-05-151.30%0.1M7.9M404.14K
2026-04-302.22%0.2M7.8M400.81K
2026-04-152.17%0.2M7.1M379.53K
2026-03-312.03%0.1M7.1M129.86K
2026-03-132.15%0.2M7.1M155.57K
2026-02-272.62%0.1M5.4M135.82K
2026-02-132.35%0.1M5.4M125.87K
2026-01-302.38%0.1M5.4M121.92K
2026-01-152.71%0.1M5.4M107.07K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-208-KCurrent report2026-10-20SEC
2026-10-078-KCurrent report2026-10-07SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-29SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-168-KCurrent report2026-09-16SEC
2026-09-148-KCurrent report2026-09-14SEC
2026-09-118-KCurrent report2026-09-08SEC
2026-09-108-KCurrent report2026-09-10SEC
2026-08-218-K/A2026-08-03SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-073Initial statement of beneficial ownership of securities2026-08-03SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-29SEC
2026-06-128-KCurrent report2026-06-12SEC
2026-06-09S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-048-KCurrent report2026-06-03SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-044Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-05-268-KCurrent report2026-05-26SEC
2026-05-198-KCurrent report2026-05-19SEC
2026-05-188-KCurrent report2026-05-18SEC
2026-05-15SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-0982.17K300
2026-080000
2026-070000
2026-060000
2026-050000
2026-04434.60K400
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Squadron Capital Management LLC9.83%
Ikarian Capital, LLC6.17%
Eversept Partners, LP3.58%
VANGUARD CAPITAL MANAGEMENT LLC2.80%
ACADIAN ASSET MANAGEMENT LLC2.07%
BOOTHBAY FUND MANAGEMENT, LLC1.70%
JANE STREET GROUP, LLC1.16%
BlackRock, Inc.1.08%
TWO SIGMA INVESTMENTS, LP1.03%
CITADEL ADVISORS LLC0.99%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.73%
VANGUARD EXTENDED MARKET INDEX FUND0.70%
Fidelity Extended Market Index Fund0.53%
Fidelity Total Market Index Fund0.11%
Fidelity Series Total Market Index Fund0.10%
TIFF MULTI-ASSET FUND0.08%
U.S. Sustainability Core 1 Portfolio0.07%
Dimensional U.S. Small Cap ETF0.07%
Dimensional US Core Equity 1 ETF0.06%
U.S. MICRO CAP PORTFOLIO0.06%

OakChart. LPCN. Cached 15 minutes.